AIBOTICS, INC.

AIBT ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2019 FY2018
Revenue $2.2K $0 $0 $0
Cost of Revenue $0 $0
Gross Profit $2.2K $0 $0 $0
Gross Margin 100.0%
Operating Expenses
Research & Development
SG&A Expense $1.8M $1.6M $123.6K $61.0K
Operating Income $-1.8M $-1.6M $-251.7K $-186.1K
Operating Margin -84,501.7%
Interest Expense $226.9K $213.5K $8 $119
Pretax Income $-2.2M $-1.8M $-253.2K $-170.3K
Income Tax Expense $0 $0 $17.4K $0
Net Income $-2.2M $-1.8M $4.8K $61.2K
Net Margin -101,500.3%
EPS (Basic) $0.00 $0.00
EPS (Diluted) $0.00 $0.00
Shares Outstanding (Basic) 486.9M 40.0M 12.4M 12.4M
Shares Outstanding (Diluted) 486.9M 40.0M 12.4M 12.4M
Dividends Per Share